Binghamton University, State University of New York

Biomedical engineers to test ultraviolet light's ability to kill coronavirus

National Science Foundation grant to fund UV research

Newswise — BINGHAMTON, NY -- The idea of UV sterilization is not a new one, but little or no scientific data about its potency against COVID-19 have been collected, until now. Thanks to a one-year, $182,728 grant from the National Science Foundation, researchers at Binghamton University, State University of New York are beginning to test UV’s effectiveness. 

As the COVID-19 pandemic spread across the world, researchers from Binghamton University’s Thomas J. Watson School of Engineering and Applied Science began work on one problem among many: How to fix the shortage of N95 medical masks.

The general practice at hospitals had been to throw away masks after each patient, but with supplies of all personal protective equipment (PPE) critically low, healthcare workers needed to use them for hours or sometimes days.

Faculty members at the Watson School’s Department of Biomedical Engineering — led by Professor and Chair Kaiming Ye — began to explore the idea of using ultraviolet light to kill the novel coronavirus. Aided by Watson staff, they built sterilization stations for Binghamton-area UHS and Lourdes hospitals, and other healthcare providers have asked for the schematics to build their own stations — including the U.K.’s National Health Service. Ye and BME Associate Professor Guy German are beginning to test UV’s effectiveness.

“This is a fundamental study that has to be done before this technology can be put into use in a hospital,” Ye said. “People are using this technology anyway without knowing for sure that it works. This grant is to fill the knowledge gap and provide data to really make sure the sterilization delivers the expected results.”

Among the questions: Which UV wavelength works best? What is the time for UV exposure to kill COVID-19? And is the ozone produced by lower-wavelength bulbs needed for sterilization? (The gas can be “quite hazardous” if inhaled, German noted.)

“If you ask anyone at the moment, ‘Is UV irradiation a good method of disinfecting?’ — you’ll probably get a lot of yeses,” German said. “If you ask, ‘What is the dosage of UV light you need to kill the virus?’ — no one knows this yet. N95 masks have a certain thickness, and UV radiation doesn’t penetrate very far into the mask, so we don’t know if it can fully sterilize it.” 

Binghamton University labs do not have the biohazard containment facilities to experiment on COVID-19 directly, so Ye and German will inoculate the masks with Bacillus bacteria, one of the most difficult strains of microorganism to kill. If the bacteria spores do not survive UV exposure, it will show that the coronavirus can be eliminated, too.

“This is a very elegant design,” Ye said. “When we talked with the program director, he was very excited that we found a way to try to conduct the study in a much safer way that generated scientifically meaningful data for the advancement of the technology.”

The Watson professors see this research as a first step that could lead to the expansion of UV technology beyond medical settings to sterilize items at home or as part of air-filtration systems in buildings or airplanes.

“I’d like to think we came up with the most salient questions that need to be answered at this juncture,” German said.

Ye and German’s study is “Ultraviolet Germicidal Irradiation for Disinfecting and Reuse of N95 Respirators” (NSF Grant #2031223).




Filters close

Showing results

110 of 2528
Released: 10-Jul-2020 3:05 PM EDT
Simple blood test can predict severity of COVID-19 for some patients
University of Texas Health Science Center at Houston

An early prognosis factor that could be a key to determining who will suffer greater effects from COVID-19, and help clinicians better prepare for these patients, may have been uncovered by researchers at The University of Texas Health Science Center at Houston (UTHealth). Results of the findings were published today in the International Journal of Laboratory Hematology.

Released: 10-Jul-2020 12:50 PM EDT
Genetic ‘fingerprints’ of first COVID-19 cases help manage pandemic
University of Sydney

A new study published in the world-leading journal Nature Medicine, reveals how genomic sequencing and mathematical modelling gave important insights into the ‘parentage’ of cases and likely spread of the disease in New South Wales.

Released: 10-Jul-2020 12:35 PM EDT
Our itch to share helps spread COVID-19 misinformation
Massachusetts Institute of Technology (MIT)

To stay current about the Covid-19 pandemic, people need to process health information when they read the news. Inevitably, that means people will be exposed to health misinformation, too, in the form of false content, often found online, about the illness.

Newswise: Pandemic Inspires Framework for Enhanced Care in Nursing Homes
Released: 10-Jul-2020 12:25 PM EDT
Pandemic Inspires Framework for Enhanced Care in Nursing Homes
University of Pennsylvania School of Nursing

As of May 2020, nursing home residents account for a staggering one-third of the more than 80,000 deaths due to COVID-19 in the U.S. This pandemic has resulted in unprecedented threats—like reduced access to resources needed to contain and eliminate the spread of the virus—to achieving and sustaining care quality even in the best nursing homes. Active engagement of nursing home leaders in developing solutions responsive to the unprecedented threats to quality standards of care delivery is required.

Newswise: General Electric Healthcare Chooses UH to Clinically 
Evaluate First-of-its-kind Imaging System
Released: 10-Jul-2020 12:15 PM EDT
General Electric Healthcare Chooses UH to Clinically Evaluate First-of-its-kind Imaging System
University Hospitals Cleveland Medical Center

University Hospitals Cleveland Medical Center physicians completed evaluation for the GE Healthcare Critical Care Suite, and the technology is now in daily clinical practice – flagging between seven to 15 collapsed lungs per day within the hospital. No one on the team could have predicted the onset of the COVID-19 pandemic, but this technology and future research with GEHC may enhance the capability to improve care for COVID-19 patients in the ICU. Critical Care Suite is now assisting in COVID and non-COVID patient care as the AMX 240 travels to intensive care units within the hospital.

Released: 10-Jul-2020 11:50 AM EDT
COVID-19 Can Be Transmitted in the Womb, Reports Pediatric Infectious Disease Journal
Wolters Kluwer Health: Lippincott Williams and Wilkins

A baby girl in Texas – born prematurely to a mother with COVID-19 – is the strongest evidence to date that intrauterine (in the womb) transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can occur, reports The Pediatric Infectious Disease Journal, the official journal of The European Society for Paediatric Infectious Diseases. The journal is published in the Lippincott portfolio by Wolters Kluwer.

Released: 10-Jul-2020 9:45 AM EDT
How COVID-19 Shifted Inpatient Imaging Utilization
Harvey L. Neiman Health Policy Institute

As medical resources shifted away from elective and non-urgent procedures toward emergent and critical care of COVID-19 patients, departments were forced to reconfigure their personnel and resources. In particular, many Radiology practices rescheduled non-urgent and routine imaging according to recommendations from the American College of Radiology (ACR). This new Harvey L. Neiman Health Policy Institute study, published online in the Journal of American College of Radiology (JACR), evaluates the change in the inpatient imaging volumes and composition mix during the COVID-19 pandemic within a large healthcare system.

access_time Embargo lifts in 2 days
Embargo will expire: 12-Jul-2020 7:00 PM EDT Released to reporters: 10-Jul-2020 9:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 12-Jul-2020 7:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 10-Jul-2020 9:00 AM EDT
Team is first in Texas to investigate convalescent plasma for prevention of COVID-19 onset and progression
University of Texas Health Science Center at Houston

A research team is the first in Texas to investigate whether plasma from COVID-19 survivors can be used in outpatient settings to prevent the onset and progression of the virus in two new clinical trials at UTHealth.


Showing results

110 of 2528

close
0.72206